Company

Suzhou Ribo Life Science

As of the edition of 20 October 2026, Suzhou Ribo Life Science runs 5 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active3
Status not established2
Total5

Where its trials are

  • Digestive system: 2 trials led
  • Infections: 2 trials led
  • Nutrition and metabolism: 1 trials led